FDA Oncology shared a post on X:
“After 48 years without new treatments, endometrial cancer finally saw breakthroughs in 2019. But 70K+ diagnoses annually demand more innovation.
Join the FDA’s September 18 panel on critical R and D priorities.
More from FDA Oncology on OncoDaily.